Meta‐Analysis of the Risk of Immune‐Related Adverse Events With Anticytotoxic T‐Lymphocyte‐Associated Antigen 4 and Antiprogrammed Death 1 Therapies

    loading  Checking for direct PDF access through Ovid

Excerpt

    loading  Loading Related Articles